Medikine
San Diego, US · 1 known investors
Find your way into Medikine
Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology. The company develops optimized therapies based on cytokine mimesis for clinical use.
Founders & leadership
WJ
William J. DowerCo-founder and Scientific Advisor
MC
Michael C. NeedelsCo-founder and CTO
RW
Ronald W. BarrettCEO and Chairman of the Board
JL
Joseph LevequeinCEO, President, and Board MemberLeveque has held chief medical officer roles at 858 Therapeutics, Mirati Therapeutics, Synthorx, ARMO BioSciences and EMD Serono, and earlier led US oncology medical affairs as a vice president at Bristol-Myers Squibb. He joined Medikine in 2022 as president and chief medical officer before serving as president and CEO from 2023 to 2025.
Investors · 1
Frequently asked questions
- What does Medikine do?
- Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology. The company develops optimized therapies based on cytokine mimesis for clinical use.
- Who founded Medikine?
- Medikine was founded by William J. Dower, Michael C. Needels, Ronald W. Barrett.
- Who are Medikine's investors?
- Medikine's investors include Bluebird Ventures.
- Where is Medikine headquartered?
- Medikine is headquartered in San Diego, US.